Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Keratoprosthesis refers to an innovative surgical procedure designed to restore vision in individuals suffering from severe corneal disease or damage. The term ‘keratoprosthesis’ is derived from the Greek words ‘kerato,’ meaning cornea, and ‘prosthesis,’ meaning artificial addition. The cornea, being…

In a significant move for the ophthalmology sector, Carl Zeiss Meditec announced the successful acquisition of 100% shares of the Dutch Ophthalmic Research Center (DORC), a transaction that has now received all necessary regulatory approvals. This acquisition from Eurazeo SE,…

Pantheon Vision, a pioneering medical device company in the pre-clinical stage focused on developing bioengineered corneal implants, has secured an additional $1.8 million in funding. This recent financial boost is part of a second tranche from KeraLink International (KLI), following…
Alcon announced the appointment of Terry Kim, MD, as the company’s new Chief Medical Officer (CMO) and Head of Global Medical Safety, starting in April. Dr. Kim, a renowned figure in the field of ophthalmology, brings a wealth of experience…

Aurion Biotech has dosed the first Canadian participant in its phase 1/2 clinical trial, known as ABA-1, CLARA. The trial investigates the efficacy and safety of AURN001, a novel cell therapy aimed at treating corneal edema resulting from corneal endothelial…

Provectus Biopharmaceuticals, Inc. has signed an exclusive global licensing agreement with the University of Miami. This partnership aims to harness the University’s pioneering photodynamic antimicrobial therapy (PDAT) for combating bacterial, fungal, and parasitic (acanthamoeba) eye infections. Launching a Start-Up for…

Vision is a critical aspect of our daily lives, enabling us to navigate our environment, engage in activities, and enjoy the beauty of the world around us. However, our eyesight can change over time, often gradually enough that we might…

CorNeat Vision has launched the CorNeat EverPatch in the United States, a novel synthetic tissue-integrating matrix poised to transform ophthalmic surgeries. Endorsed by leading surgeons across the US, this FDA-cleared device marks a significant advancement in addressing complications associated with…

Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announced the appointment of Dr. Eric D. Donnenfeld, a distinguished figure in ophthalmology, as the Chair of its U.S. Medical Advisory Board (MAB). This strategic decision comes as the company gears…

The Brightness of Divine Glance In Ancient Egypt One of the first civilizations in human history is that of ancient Egypt. The pioneering work of the ancient Egyptians in the domains of art, medicine, and the mythological storytelling of scientific…